 |
| “We conducted an exhaustive search of EDC vendors that drilled down to 30
high level candidates. Ten (10) of those companies were issued a request for proposal
and only 4 leading companies were chosen to provide demonstrations of their products
and services. OmniComm exceeded our expectations with the best services and
software by far and was the clear winner in the evaluation. We are very excited to have
made the move to EDC and we look forward to working in tandem with the team at
OmniComm.” |
Evan King, COO Colorado Prevention Center |
| |
 |
| “Criterium has been in the business of providing high-quality,
global clinical trial support services to the drug development industry for nearly 20 years.
We have had the opportunity to become familiar with many of the EDC systems in the
marketplace and have chosen TrialMaster based on its superior functionality and
compatibility with Criterium’s StudyControl™, our centralized clinical trial data
management environment. We appreciate the right mix of a superior EDC product and
the real dedication to customer service that the OmniComm-Criterium team delivers.” |
John Hudak, President and Founder of Criterium |
| |
 |
| “Pleiad’s clinical research team has years of experience in designing,
organizing and managing clinical projects for medical device companies. Over the years,
our team has had experience with most of the EDC vendors in the marketplace.
TrialMaster is one of the best EDC products that we have seen and we look forward to
offering our medical device customers this premier service.” |
Stephen Brandao, Vice President of Business Development, Pleiad Devices |
| |
 |
| "QST's clients range from small start-ups to large major pharmaceutical
companies that conduct complex clinical studies and they all expect and deserve a
superior level of personalized service, technical expertise and quality deliverables. We
have selected OmniComm as our partner to provide EDC because having worked with
them in the past we knew that they were a good match to satisfy our clients'
expectations. It is important for us to use a full service EDC provider whose capabilities
include both a strong technology product and support services that complement our own
efforts.” |
John Quiring, Ph.D., President of QST Consultations |
| |
 |
| "The collaboration with OmniComm allows Pharmatech to blend our
expertise in the community-based oncology setting with OmniComm's strength in the
hospital and academic settings to provide real power to oncology clinical trials. The
OmniComm e-clinical trial platform will boost the development of our progressive clinical
trials business model by further building upon our innovative patient enrollment and data
management programs.” |
Matthew Wiener, CEO of Pharmatech |
| |
 |
| “TrialMaster’s flexibility and OmniComm’s customer service were
key factors in the selection process. We look forward to a long and continued
relationship going forward.” |
Annetine Gelijns, Co-Director of InChoir, Columbia University |
| |
 |
| “We have enjoyed a very successful relationship with OmniComm Systems for many
years now. They bring to the table a first class EDC product, attention to detail and
responsiveness to our needs. This is particularly important during the implementation
process when timelines are tight. We have found them to be an ideal business partner.” |
Tony Lamas, M.D., Director of Cardiovascular Research and Academic Affairs
Mount Sinai Medical Center and Principal Investigator, TACT and PACT Studies,
National Heart Lung & Blood Institute (NHLBI) |
| |
 |
| “Asthmatx requires complete and accurate collection of clinical
research data and the ability to analyze the data in the shortest time possible after a
database “freeze” or lock. The capabilities of OmniComm’s’ EDC solution promises to
save Asthmatx time and money. We selected the TrialMaster solution because of its
ease of use and flexible structure. The integrated platform should enable Asthmatx to
save valuable time and provide control over critical trial processes.” |
Glendon E. French, President and CEO, Asthmatx |
| |
 |
| "We are pleased to be partnering with OmniComm, a company that has
demonstrated its experience and ability in delivering comprehensive clinical data
solutions on a global basis. Use of the TrialMaster system has allowed us to build a
robust data management and safety review process and we are confident that
TrialMaster will continue to enhance our efficiency in the drug discovery process." |
Erik Henricson, MPH, CINRG Researcher and Coordinator of the Network |
